NLS Pharmaceutics AG (NLSP)
NLS Pharmaceutics AG Statistics
Share Statistics
NLS Pharmaceutics AG has 2.47M shares outstanding. The number of shares has increased by -93.07% in one year.
Shares Outstanding | 2.47M |
Shares Change (YoY) | -93.07% |
Shares Change (QoQ) | 110.96% |
Owned by Institutions (%) | 22.34% |
Shares Floating | 1.57M |
Failed to Deliver (FTD) Shares | 6.39K |
FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 85.78K, so 3.47% of the outstanding shares have been sold short.
Short Interest | 85.78K |
Short % of Shares Out | 3.47% |
Short % of Float | 5.26% |
Short Ratio (days to cover) | 0.04 |
Valuation Ratios
The PE ratio is -73.77 and the forward PE ratio is -3.42. NLS Pharmaceutics AG's PEG ratio is 1.19.
PE Ratio | -73.77 |
Forward PE | -3.42 |
PS Ratio | 0 |
Forward PS | 0 |
PB Ratio | -101.65 |
P/FCF Ratio | -92.72 |
PEG Ratio | 1.19 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics AG.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23, with a Debt / Equity ratio of -0.18.
Current Ratio | 0.23 |
Quick Ratio | 0.23 |
Debt / Equity | -0.18 |
Total Debt / Capitalization | -22.69 |
Cash Flow / Debt | -5.93 |
Interest Coverage | -81.34 |
Financial Efficiency
Return on equity (ROE) is 1.38% and return on capital (ROIC) is 163.99%.
Return on Equity (ROE) | 1.38% |
Return on Assets (ROA) | -6.59% |
Return on Capital (ROIC) | 163.99% |
Revenue Per Employee | $0 |
Profits Per Employee | $-2,028,671.5 |
Employee Count | 6 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -87.29% in the last 52 weeks. The beta is -0.3, so NLS Pharmaceutics AG's price volatility has been lower than the market average.
Beta | -0.3 |
52-Week Price Change | -87.29% |
50-Day Moving Average | 2.05 |
200-Day Moving Average | 4.8 |
Relative Strength Index (RSI) | 40.06 |
Average Volume (20 Days) | 2.97M |
Income Statement
Revenue | n/a |
Gross Profit | -11.41K |
Operating Income | -11.81M |
Net Income | -12.17M |
EBITDA | -11.8M |
EBIT | n/a |
Earnings Per Share (EPS) | -0.32 |
Balance Sheet
The company has 897.68K in cash and 1.63M in debt, giving a net cash position of -736.07K.
Cash & Cash Equivalents | 897.68K |
Total Debt | 1.63M |
Net Cash | -736.07K |
Retained Earnings | -70.37M |
Total Assets | 1.19M |
Working Capital | -6.53M |
Cash Flow
In the last 12 months, operating cash flow was -9.68M and capital expenditures -4, giving a free cash flow of -9.68M.
Operating Cash Flow | -9.68M |
Capital Expenditures | -4 |
Free Cash Flow | -9.68M |
FCF Per Share | -0.25 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NLSP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -17.98% |
FCF Yield | -220.05% |
Analyst Forecast
Currently there are no analyst rating for NLSP.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 27, 2024. It was a backward split with a ratio of 1:40.
Last Split Date | Sep 27, 2024 |
Split Type | backward |
Split Ratio | 1:40 |
Scores
Altman Z-Score | -148.49 |
Piotroski F-Score | 1 |